4-(2-hydroxy-1,1-dimethyl-ethyl)-N-(6-(2-hydroxy-ethoxy)-5-(2-methoxy-phenoxy)-2-purin-6-yl-pyrimidin-6-yl)-benzenesulfonamide,
Ro 48-5033,
Hydroxy Bosentan,
253688-60-7,
Ro 48-5033,
Ro 48-8634,
Hydroxybosentan,
AC1O52KY,
SCHEMBL7205072,
CHEMBL3901721,
CTK8F1292,
FAJQMBCLPZWTQJ-UHFFFAOYSA-N,
Bosentan metabolite Ro 48-5033,
ZINC72131388,
AKOS030239680,
ACM253688607,
ACM1246817571,
RT-013269,
FT-0669430,
J-015960,
4-(2-Hydroxy-1,1-dimethylethyl)-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)[2,2'-bipyrimidin]-4-yl]-benzenesulfonamide,
Benzenesulfonamide, 4-(2-hydroxy-1,1-dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)(2,2'-bipyrimidin)-4-yl)-,
N-[4-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-(2-pyrimidinyl)pyrimidin-6-yl]-4-(2-hydroxy-1,1-dimethylethyl)benzenesulphonamide,
N-[4-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-(2-pyrimidinyl)pyrimidin-6-yl]4-(2-hydroxy-1,1-dimethylethyl)benzenesulphonamide,
N-[6-(2-Hydroxyethoxy)-5-(2-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl]-4-(2-hydroxy-1,1-dimethylethyl)benzenesulfonamide,
N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]-4-(1-hydroxy-2-methylpropan-2-yl)benzenesulfonamide,
Hydroxy Bosentan-d4,
Hydroxy Bosentan-d6,
CID6426755,
CS-O-10316,
CID 6426755,
1065472-91-4,
1246817-57-1,